These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

145 related items for PubMed ID: 9167004

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Characterisation of vaccine-derived polioviruses isolated from sewage and river water in Japan.
    Yoshida H, Horie H, Matsuura K, Miyamura T.
    Lancet; 2000 Oct 28; 356(9240):1461-3. PubMed ID: 11081527
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Oral poliovirus vaccine type 3 from a patient with transverse myelitis is neurovirulent in a transgenic mouse model.
    Thorley B, Kelly H, Nishimura Y, Yoon YK, Brussen KA, Roberts J, Shimizu H.
    J Clin Virol; 2009 Apr 28; 44(4):268-71. PubMed ID: 19269246
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Assessment of the viral RNA sequence heterogeneity for control of OPV neurovirulence.
    Chumakov K, Norwood L, Parker M, Dragunsky E, Taffs R, Ran Y, Ridge J, Levenbook I.
    Dev Biol Stand; 1993 Apr 28; 78():79-89; discussion 88-9. PubMed ID: 8388834
    [Abstract] [Full Text] [Related]

  • 30. Potency of wild-type or sabin trivalent inactivated poliovirus vaccine, by enzyme-linked immunosorbent assay using monoclonal antibiotics specific for each antigenic site.
    Sawyer LA, Wood D, Ferguson M, Crainic R, Beuvery EC, McInnis J, Albrecht P.
    Biologicals; 1997 Sep 28; 25(3):299-306. PubMed ID: 9324998
    [Abstract] [Full Text] [Related]

  • 31. Chronic progressive poliomyelitis secondary to vaccination of an immunodeficient child.
    Davis LE, Bodian D, Price D, Butler IJ, Vickers JH.
    N Engl J Med; 1977 Aug 04; 297(5):241-5. PubMed ID: 195206
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Analysis of mutations in oral poliovirus vaccine by hybridization with generic oligonucleotide microchips.
    Proudnikov D, Kirillov E, Chumakov K, Donlon J, Rezapkin G, Mirzabekov A.
    Biologicals; 2000 Jun 04; 28(2):57-66. PubMed ID: 10885613
    [Abstract] [Full Text] [Related]

  • 37. On the role of the World Health Organization in the development of Sabin vaccines.
    Magrath D, Reeve P.
    Biologicals; 1993 Dec 04; 21(4):345-8. PubMed ID: 8024749
    [Abstract] [Full Text] [Related]

  • 38. Genetic stability of Sabin 1 strain of poliovirus: implications for quality control of oral poliovirus vaccine.
    Rezapkin GV, Alexander W, Dragunsky E, Parker M, Pomeroy K, Asher DM, Chumakov KM.
    Virology; 1998 Jun 05; 245(2):183-7. PubMed ID: 9636357
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. New approaches to poliovirus diagnosis using laboratory techniques: memorandum from a WHO meeting.
    Bull World Health Organ; 1992 Jun 05; 70(1):27-33. PubMed ID: 1348972
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.